10-K/A: ALT5 Sigma Corporation Files Amendment to 2023 Annual Report to Correct Exhibit Dates
Form 10-K/A Amendment
ALT5 Sigma Corporation files an amendment to its 2023 annual report to correct misdated exhibits related to Sarbanes-Oxley Act certifications.
Summary
- ALT5 Sigma Corporation is filing an amendment to its Annual Report on Form 10-K for the fiscal year ended December 30, 2023.
- The purpose of the amendment is to file corrected versions of Exhibits 31.1, 31.2, 32.1, and 32.2, which were initially misdated.
- The corrected exhibits include certifications by the President and CFO pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.
- The amendment does not include any other changes to the original Annual Report.
- The company's common stock is registered on the Nasdaq Capital Market under the trading symbol ALTS.
- As of April 8, 2024, there were 8,593,636 shares of the company's common stock outstanding.
Sentiment
Score: 7
Explanation: The document is a routine amendment to correct errors, indicating a neutral to slightly positive sentiment as the company is taking steps to ensure accurate reporting.
Positives
- The company is taking corrective action to ensure accurate filings with the SEC.
- The certifications by the President and CFO affirm the accuracy and compliance of the financial reporting.
Management Comments
- Tony Isaac, President, certifies that the report complies with Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and fairly presents the company's financial condition and results of operations.
- Virland A. Johnson, Chief Financial Officer, provides a similar certification regarding the report's compliance and accuracy.
Industry Context
This filing is a routine amendment to correct administrative errors in the original filing, ensuring compliance with SEC regulations and maintaining investor confidence.
Stakeholder Impact
- The amendment ensures that stakeholders receive accurate and reliable financial information.
- Correcting the misdated exhibits demonstrates a commitment to transparency and compliance.
Key Dates
| Date | Description |
|---|---|
| December 30, 2023 | Fiscal year ended |
| July 1, 2023 | Date used to calculate aggregate market value of non-affiliate common stock |
| April 8, 2024 | Date of outstanding common stock calculation |
| March 25, 2025 | Date of amendment filing and signatures |
Keywords
amendment, annual report, Form 10-K, Sarbanes-Oxley Act, certification, exhibits, financial reporting, ALT5 Sigma Corporation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.